Evidence map›Paper›PMID 30487274›Full record

ArticleJournal of virology2019

Cell Cycle Arrest in G

Christian Bressy, Gaith N Droby, Bryant D Maldonado, Nury Steuerwald, Valery Z Grdzelishvili

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Article
  3. Article
  4. N6-methyladenosine modification of FZR1 mRNA positively regulates antiviral innate immunity by targeting the MAVS-TRAF3/6 axis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis.Journal of cardiovascular translational research · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Christian BressyDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.
Gaith N DrobyDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.
Bryant D MaldonadoDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.
Nury SteuerwaldLevine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Valery Z GrdzelishviliDepartment of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina, USA vzgrdzel@uncc.edu.
University of North Carolina at Charlotte · USLevine Cancer Institute · US

Funding

CELLULAR PATHWAYS AFFECTING ONCOLYTIC VIRUS-HOST INTERACTIONS IN CANCERR15CA195463 · NCI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI GRDZELISHVILI, VALERY ZURABOVICH · 2016 to 2016
$445k
NCI NIH HHS R15 CA195463
6 · The paper itself

Abstract

Vesicular stomatitis virus (VSV) (a rhabdovirus) and its variant VSV-ΔM51 are widely used model systems to study mechanisms of virus-host interactions. Here, we investigated how the cell cycle affects replication of these viruses using an array of cell lines with different levels of impairment of antiviral signaling and a panel of chemical compounds arresting the cell cycle at different phases. We observed that all compounds inducing cell cycle arrest in G

Indexed as

AnimalsAntiviral AgentsCell Cycle CheckpointsCell Line, TumorCytoplasmG2 PhaseG2 Phase Cell Cycle CheckpointsGene ExpressionHumansInterferon-gammaInterferon LambdaInterferonsInterferon Type IM Phase Cell Cycle CheckpointsOncolytic VirotherapyOncolytic VirusesAntiviral AgentsInterferon-gammaInterferon LambdaInterferonsInterferon Type IViral Matrix Proteinscell cyclecolchicineG2/Mmitotic inhibition of transcriptionnonsegmented negative-strand RNA viruspaclitaxelSendai virustype I interferonvesicular stomatitis virus

Identifiers

PMID30487274
PMCPMC6364032
OpenAlexW2903090971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.